Company
Company

Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

Généthon

Main focus: Gene therapies and gene editing for the treatment of genetic diseases

Company stage: Clinical

Diseases (gene editing): Sickle cell disease, beta-thalassemia, duchenne muscular dystrophy, lysosomal metabolic diseases

Genome editing tool: CRISPR-Cas9

Funding stage: Private

Location: Évry, Ile-de-France, France

Website: https://www.genethon.com/

Pipeline: https://www.genethon.com/our-therapies/

Généthon is a French company focused on the development of gene therapies directed towards rare diseases. The company develops gene-editing based therapies as well as other types of gene therapies. Its gene-editing activities are centered around haematopoietic stem cells and blood disorders, such as sickle cell disease.

Tags

HashtagGénéthon

Company: Généthon
Jobs, banner ads, webinars, sponsored content...
close
Search CRISPR Medicine